| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | -0.0058 | 0.9 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | 0.0049 | 0.9 |
| mRNA | GSK4112 | CTRPv2 | pan-cancer | AAC | 0.0054 | 0.9 |
| mRNA | Axitinib | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.01 | 0.9 |
| mRNA | KIN001-266 | GDSC1000 | pan-cancer | AAC | -0.0049 | 0.9 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | PF-184 | CTRPv2 | pan-cancer | AAC | 0.0047 | 0.9 |
| mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | -0.006 | 0.9 |
| mRNA | BRD-K35604418 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |